Preserving fertility in children and adolescents with cancer

Children

Volumn 1, Issue 2, 2014, Pages 166-185

  Levine, Jennifer M ^a  

^a Department of Medicine   (United States)

Author keywords

Fertility; Late effects; Pediatric cancer; Survivorship

Indexed keywords

EID: 84977490781     PISSN: None     EISSN: 22279067     Source Type: Journal    
DOI: 10.3390/children1020166     Document Type: Review

References (101)

1. Ward, E.; DeSantis, C.; Robbins, A.; Kohler, B.; Jemal, A. Childhood and adolescent cancer statistics, 2014. CA Cancer J. Clin. 2014, 64, 83–103.
2. Oeffinger, K.C.; Mertens, A.C.; Sklar, C.A.; Kawashima, T.; Hudson, M.M.; Meadows, A.T.; Friedman, D.L.; Marina, N.; Hobbie, W.; Kadan-Lottick, N.S.; et al. Chronic health conditions in adult survivors of childhood cancer. N. Engl. J. Med. 2006, 355, 1572–1582.
3. Green, D.M.; Kawashima, T.; Stovall, M.; Leisenring, W.; Sklar, C.A.; Mertens, A.C.; Donaldson, S.S.; Byrne, J.; Robison, L.L. Fertility of male survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. J. Clin. Oncol. 2010, 28, 332–339.
4. Green, D.M.; Sklar, C.A.; Boice, J.D., Jr.; Mulvihill, J.J.; Whitton, J.A.; Stovall, M.; Yasui, Y. Ovarian failure and reproductive outcomes after childhood cancer treatment: Results from the Childhood Cancer Survivor Study. J. Clin. Oncol. 2009, 27, 2374–2381.
5. Jeruss, J.S.; Woodruff, T.K. Preservation of fertility in patients with cancer. N. Engl. J. Med. 2009, 360, 902–911.
6. Schover, L.R. Psychosocial aspects of infertility and decisions about reproduction in young cancer survivors: A review. Med. Pediatr. Oncol. 1999, 33, 53–59.
7. Langeveld, N.E.; Grootenhuis, M.A.; Voute, P.A.; de Haan, R.J.; van den Bos, C. Quality of life, self-esteem and worries in young adult survivors of childhood cancer. Psychooncology 2004, 13, 867–881.
8. Levine, J.; Canada, A.; Stern, C.J. Fertility preservation in adolescents and young adults with cancer. J. Clin. Oncol. 2010, 28, 4831–4841.
9. Practice Committee of American Society for Reproductive, M. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: A committee opinion. Fertil. Steril. 2013, 100, 1214–1223.
10. National Institute for Health and Care Excellence. Fertility: Assessment and treatment for people with fertility problems: Clinical guideline 156. Available online: http://www.nice.org.uk/guidance/cg156/resources/guidance-fertility-pdf (accessed on 19 July 2014).
11. Loren, A.W.; Mangu, P.B.; Beck, L.N.; Brennan, L.; Magdalinski, A.J.; Partridge, A.H.; Quinn, G.; Wallace, W.H.; Oktay, K.; American Society of Clinical, O. Fertility preservation for patients with cancer: American society of clinical oncology clinical practice guideline update. J. Clin. Oncol. 2013, 31, 2500–2510.
12. Coccia, P.F.; Pappo, A.S.; Altman, J.; Bhatia, S.; Borinstein, S.C.; Flynn, J.; Frazier, A.L.; George, S.; Goldsby, R.; Hayashi, R.; et al. Adolescent and young adult oncology, version 2.2014. J. Natl. Compr. Canc. Netw. 2014, 12, 21–32.
13. AYA cancer fertility preservation guidance working group Cancer Council Australia. Fertility preservation for AYAs diagnosed with cancer: Guidance for health professionals. http://wiki.cancer.org.au/australia/COSA:AYA_cancer_fertility_preservation (accessed on 19 July 2014).
14. National Child Cancer Network New Zealand. Fertility preservation for people with cancer. Available online: https://www.starship.org.nz/for-health-professionals/national-guidelines-paediatric-oncology-and-haematology (accessed on 21 August 2014).
15. International Society for Fertility Preservation; Kim, S.S.; Donnez, J.; Barri, P.; Pellicer, A.; Patrizio, P.; Rosenwaks, Z.; Nagy, P.; Falcone, T.; Andersen, C.; et al. Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer. J. Assist. Reprod. Genet. 2012, 29, 465–468.
16. Eshre Task Force on Ethics. Taskforce 7: Ethical considerations for the cryopreservation of gametes and reproductive tissues for self use. Hum. Reprod. 2004, 19, 460–462.
17. Yeomanson, D.J.; Morgan, S.; Pacey, A.A. Discussing fertility preservation at the time of cancer diagnosis: Dissatisfaction of young females. Pediatr. Blood Cancer 2013, 60, 1996–2000.
18. Goodwin, T.; Elizabeth Oosterhuis, B.; Kiernan, M.; Hudson, M.M.; Dahl, G.V. Attitudes and practices of pediatric oncology providers regarding fertility issues. Pediatr. Blood Cancer 2007, 48, 80–85.
19. Quinn, G.P.; Vadaparampil, S.T.; King, L.; Miree, C.A.; Wilson, C.; Raj, O.; Watson, J.; Lopez, A.; Albrecht, T.L. Impact of physicians' personal discomfort and patient prognosis on discussion of fertility preservation with young cancer patients. Patient Educ. Couns. 2009, 77, 338–343.
20. Peddie, V.L.; Porter, M.A.; Barbour, R.; Culligan, D.; MacDonald, G.; King, D.; Horn, J.; Bhattacharya, S. Factors affecting decision making about fertility preservation after cancer diagnosis: A qualitative study. BJOG 2012, 119, 1049–1057.
21. Kohler, T.S.; Kondapalli, L.A.; Shah, A.; Chan, S.; Woodruff, T.K.; Brannigan, R.E. Results from the survey for preservation of adolescent reproduction (SPARE) study: Gender disparity in delivery of fertility preservation message to adolescents with cancer. J. Assist. Reprod. Genet. 2011, 28, 269–277.
22. Reinecke, J.D.; Kelvin, J.F.; Arvey, S.R.; Quinn, G.P.; Levine, J.; Beck, L.N.; Miller, A. Implementing a systematic approach to meeting patients' cancer and fertility needs: A review of the fertile hope centers of excellence program. J. Oncol. Pract. 2012, 8, 303–308.
23. Johnston, R.J.; Wallace, W.H. Normal ovarian function and assessment of ovarian reserve in the survivor of childhood cancer. Pediatr. Blood Cancer 2009, 53, 296–302.
24. Charpentier, A.M.; Chong, A.L.; Gingras-Hill, G.; Ahmed, S.; Cigsar, C.; Gupta, A.A.; Greenblatt, E.; Hodgson, D.C. Anti-Mullerian hormone screening to assess ovarian reserve among female survivors of childhood cancer. J. Cancer Surviv. 2014; doi:10.1007/s11764-014-0364-4.
25. Meirow, D. Ovarian injury and modern options to preserve fertility in female cancer patients treated with high dose radio-chemotherapy for hemato-oncological neoplasias and other cancers. Leuk. Lymphoma 1999, 33, 65–76.
26. Wallace, W.H.; Shalet, S.M.; Hendry, J.H.; Morris-Jones, P.H.; Gattamaneni, H.R. Ovarian failure following abdominal irradiation in childhood: The radiosensitivity of the human oocyte. Br. J. Radiol. 1989, 62, 995–998.
27. Metzger, M.L.; Meacham, L.R.; Patterson, B.; Casillas, J.S.; Constine, L.S.; Hijiya, N.; Kenney, L.B.; Leonard, M.; Lockart, B.A.; Likes, W.; et al. Female reproductive health after childhood, adolescent, and young adult cancers: Guidelines for the assessment and management of female reproductive complications. J. Clin. Oncol. 2013, 31, 1239–1247.
28. Dillon, K.E.; Sammel, M.D.; Prewitt, M.; Ginsberg, J.P.; Walker, D.; Mersereau, J.E.; Gosiengfiao, Y.; Gracia, C.R. Pretreatment antimullerian hormone levels determine rate of posttherapy ovarian reserve recovery: Acute changes in ovarian reserve during and after chemotherapy. Fertil. Steril. 2013, 99, 477–483.
29. Chemaitilly, W.; Mertens, A.C.; Mitby, P.; Whitton, J.; Stovall, M.; Yasui, Y.; Robison, L.L.; Sklar, C.A. Acute ovarian failure in the childhood cancer survivor study. J. Clin. Endocrinol. Metab. 2006, 91, 1723–1728.
30. Sklar, C.A.; Mertens, A.C.; Mitby, P.; Whitton, J.; Stovall, M.; Kasper, C.; Mulder, J.; Green, D.; Nicholson, H.S.; Yasui, Y.; et al. Premature menopause in survivors of childhood cancer: A report from the childhood cancer survivor study. J. Natl. Cancer Inst. 2006, 98, 890–896.
31. Signorello, L.B.; Mulvihill, J.J.; Green, D.M.; Munro, H.M.; Stovall, M.; Weathers, R.E.; Mertens, A.C.; Whitton, J.A.; Robison, L.L.; Boice, J.D., Jr. Stillbirth and neonatal death in relation to radiation exposure before conception: A retrospective cohort study. Lancet 2010, 376, 624–630.
32. Littley, M.D.; Shalet, S.M.; Beardwell, C.G.; Ahmed, S.R.; Applegate, G.; Sutton, M.L. Hypopituitarism following external radiotherapy for pituitary tumours in adults. Q. J. Med. 1989, 70, 145–160.
33. Green, D.M.; Nolan, V.G.; Kawashima, T.; Stovall, M.; Donaldson, S.S.; Srivastava, D.; Leisenring, W.; Robison, L.L.; Sklar, C.A. Decreased fertility among female childhood cancer survivors who received 22–27 Gy hypothalamic/pituitary irradiation: A report from the Childhood Cancer Survivor Study. Fertil. Steril. 2011, 95, 1922–1927.
34. Practice Committees of American Society for Reproductive, M.; Society for Assisted Reproductive, T. Mature oocyte cryopreservation: A guideline. Fertil. Steril. 2013, 99, 37–43.
35. Society for Assisted Reproduction. Available online: http://www.sart.org/find_frm.html (accessed on 20 August 2014).
36. Human Fertilisation and Embryology Authority. Available online: http://guide.hfea.gov.uk/guide/(accessed on 20 August 2014).
37. Noyes, N.; Porcu, E.; Borini, A. Over 900 oocyte cryopreservation babies born with no apparent increase in congenital anomalies. Reprod. Biomed. Online 2009, 18, 769–776.
38. Bedoschi, G.M.; de Albuquerque, F.O.; Ferriani, R.A.; Navarro, P.A. Ovarian stimulation during the luteal phase for fertility preservation of cancer patients: Case reports and review of the literature. J. Assist. Reprod. Genet. 2010, 27, 491–494.
39. Livestrong Foundation. Available online: http://www.livestrong.org/we-can-help/fertility-services/fertility-preservation-options-women/(accessed on 28 May 2014).
40. Livestrong Foundation. Available online: http://www.livestrong.org/we-can-help/fertility/#tab2 (accessed on 20 August 2014).
41. Partridge, A.H. Ovarian suppression for prevention of premature menopause and infertility: Empty promise or effective therapy? J. Clin. Oncol. 2012, 30, 479–481.
42. Beck-Fruchter, R.; Weiss, A.; Shalev, E. GnRH agonist therapy as ovarian protectants in female patients undergoing chemotherapy: A review of the clinical data. Hum. Reprod. Update 2008, 14, 553–561.
43. Badawy, A.; Elnashar, A.; El-Ashry, M.; Shahat, M. Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: Prospective randomized study. Fertil. Steril. 2009, 91, 694–697.
44. Del Mastro, L.; Boni, L.; Michelotti, A.; Gamucci, T.; Olmeo, N.; Gori, S.; Giordano, M.; Garrone, O.; Pronzato, P.; Bighin, C.; et al. Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: A randomized trial. JAMA 2011, 306, 269–276.
45. Sverrisdottir, A.; Nystedt, M.; Johansson, H.; Fornander, T. Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: Results from a randomized trial. Breast Cancer Res. Treat. 2009, 117, 561–567.
46. Gerber, B.; von Minckwitz, G.; Stehle, H.; Reimer, T.; Felberbaum, R.; Maass, N.; Fischer, D.; Sommer, H.L.; Conrad, B.; Ortmann, O.; et al. Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: The GBG 37 ZORO study. J. Clin. Oncol. 2011, 29, 2334–2341.
47. Munster, P.N.; Moore, A.P.; Ismail-Khan, R.; Cox, C.E.; Lacevic, M.; Gross-King, M.; Xu, P.; Carter, W.B.; Minton, S.E. Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer. J. Clin. Oncol. 2012, 30, 533–538.
48. Behringer, K.; Wildt, L.; Mueller, H.; Mattle, V.; Ganitis, P.; van den Hoonaard, B.; Ott, H.W.; Hofer, S.; Pluetschow, A.; Diehl, V.; et al. No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase II trial from the German Hodgkin Study Group. Ann. Oncol. 2010, 21, 2052–2060.
49. Moore, H.C.F.; Unger, J.M.; Phillips, K.; Boyle, F.M.; Hitre, E.; Porter, D.J.; Francis, P.A.; Minasian, L.M.; Gelber, R.D.; Goldstein, L.J.; et al. Phase III trial (Prevention of Early Menopause Study [POEMS]-SWOG S0230) of LHRH analog during chemotherapy (CT) to reduce ovarian failure in early-stage, hormone receptor-negative breast cancer: An international Intergroup trial of SWOG, IBCSG, ECOG, and CALGB (Alliance). J. Clin. Oncol. 2014, 32. Abstract number: LBA505.
50. Gracia, C.R.; Chang, J.; Kondapalli, L.; Prewitt, M.; Carlson, C.A.; Mattei, P.; Jeffers, S.; Ginsberg, J.P. Ovarian tissue cryopreservation for fertility preservation in cancer patients: Successful establishment and feasibility of a multidisciplinary collaboration. J. Assist. Reprod. Genet. 2012, 29, 495–502.
51. Kim, S.S. Fertility preservation in female cancer patients: Current developments and future directions. Fertil. Steril. 2006, 85, 1–11.
52. Donnez, J.; Dolmans, M.M. Fertility preservation in women. Nat. Rev. Endocrinol. 2013, 9, 735–749.
53. Babayev, S.N.; Arslan, E.; Kogan, S.; Moy, F.; Oktay, K. Evaluation of ovarian and testicular tissue cryopreservation in children undergoing gonadotoxic therapies. J. Assist. Reprod. Genet. 2013, 30, 3–9.
54. Smitz, J.; Dolmans, M.M.; Donnez, J.; Fortune, J.E.; Hovatta, O.; Jewgenow, K.; Picton, H.M.; Plancha, C.; Shea, L.D.; Stouffer, R.L.; et al. Current achievements and future research directions in ovarian tissue culture, in vitro follicle development and transplantat ion: Implications for fertility preservation. Hum. Reprod. Update 2010, 16, 395–414.
55. Dolmans, M.M.; Marinescu, C.; Saussoy, P.; Van Langendonckt, A.; Amorim, C.; Donnez, J. Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblast ic leukemia is potentially unsafe. Blood 2010, 116, 2908–2914.
56. Terenziani, M.; Piva, L.; Meazza, C.; Gandola, L.; Cefalo, G.; Merola, M. Oophoropexy: A relevant role in preservation of ovarian function after pelvic irradiation. Fertil. Steril. 2009, 91, 935.e15-935.e16.
57. Anderson, R.A.; Weddell, A.; Spoudeas, H.A.; Douglas, C.; Shalet, S.M.; Levitt, G.; Wallace, W.H. Do doctors discuss fertility issues before they treat young patients with cancer? Hum. Reprod. 2008, 23, 2246–2251.
58. Quinn, G.P.; Murphy, D.; Knapp, C.; Stearsman, D.K.; Bradley-Klug, K.L.; Sawczyn, K.; Clayman, M.L. Who decides? Decision making and fertility preservation in teens with cancer: A review of the literature. J. Adolesc. Health 2011, 49, 337–346.
59. Anderson, R.A.; Wallace, W.H. Antimullerian hormone, the assessment of the ovarian reserve, and the reproductive outcome of the young patient with cancer. Fertil. Steril. 2013, 99, 1469–1475.
60. Peigne, M.; Decanter, C. Serum AMH level as a marker of acute and long-term effects of chemotherapy on the ovarian follicular content: A systematic review. Reprod. Biol. Endocrinol. 2014, 12, 26.
61. Bath, L.E.; Wallace, W.H.; Shaw, M.P.; Fitzpatrick, C.; Anderson, R.A. Depletion of ovarian reserve in young women after treatment for cancer in childhood: Detection by anti-Mullerian hormone, inhibin B and ovarian ultrasound. Hum. Reprod. 2003, 18, 2368–2374.
62. Dillon, K.E.; Sammel, M.D.; Ginsberg, J.P.; Lechtenberg, L.; Prewitt, M.; Gracia, C.R. Pregnancy after cancer: Results from a prospective cohort study of cancer survivors. Pediatr. Blood Cancer 2013, 60, 2001–2006.
63. Barton, S.E.; Najita, J.S.; Ginsburg, E.S.; Leisenring, W.M.; Stovall, M.; Weathers, R.E.; Sklar, C.A.; Robison, L.L.; Diller, L. Infertility, infertility treatment, and achievement of pregnancy in female survivors of childhood cancer: A report from the childhood cancer survivor study cohort. Lancet Oncol. 2013, 14, 873–881.
64. Meistrich, M.L. Male gonadal toxicity. Pediatr. Blood Cancer 2009, 53, 261–266.
65. Shetty, G.; Meistrich, M.L. Hormonal approaches to preservation and restoration of male fertility after cancer treatment. J. Natl. Cancer Inst. Monogr. 2005, 34, 36–39.
66. Wyrobek, A.J.; Schmid, T.E.; Marchetti, F. Relative susceptibilities of male germ cells to genetic defects induced by cancer chemotherapies. J. Natl. Cancer Inst. Monogr. 2005, 34, 31–35.
67. Kenney, L.B.; Laufer, M.R.; Grant, F.D.; Grier, H.; Diller, L. High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood. Cancer 2001, 91, 613–621.
68. Trottmann, M.; Becker, A.J.; Stadler, T.; Straub, J.; Soljanik, I.; Schlenker, B.; Stief, C.G. Semen quality in men with malignant diseases before and after therapy and the role of cryopreservation. Eur. Urol. 2007, 52, 355–367.
69. Jahnukainen, K.; Stukenborg, J.B. Clinical review: Present and future prospects of male fertility preservation for children and adolescents. J. Clin. Endocrinol. Metab. 2012, 97, 4341–4351.
70. Kenney, L.B.; Cohen, L.E.; Shnorhavorian, M.; Metzger, M.L.; Lockart, B.; Hijiya, N.; Duffey-Lind, E.; Constine, L.; Green, D.; Meacham, L. Male reproductive health after childhood, adolescent, and young adult cancers: A report from the Children’s Oncology Group. J. Clin. Oncol. 2012, 30, 3408–3416.
71. Vigersky, R.A.; Chapman, R.M.; Berenberg, J.; Glass, A.R. Testicular dysfunction in untreated hodgkin's disease. Am. J. Med. 1982, 73, 482–486.
72. Petersen, P.M.; Skakkebaek, N.E.; Vistisen, K.; Rorth, M.; Giwercman, A. Semen quality and reproductive hormones before orchiectomy in men with testicular cancer. J. Clin. Oncol. 1999, 17, 941–947.
73. Howell, S.J.; Shalet, S.M. Spermatogenesis after cancer treatment: Damage and recovery. J. Natl. Cancer Inst. Monogr. 2005, 34, 12–17.
74. Shin, D.; Lo, K.C.; Lipshultz, L.I. Treatment options for the infertile male with cancer. J. Natl. Cancer Inst. Monogr. 2005, 34, 48–50.
75. Feldschuh, J.; Brassel, J.; Durso, N.; Levine, A. Successful sperm storage for 28 years. Fertil. Steril. 2005, 84, 1017.
76. Ginsberg, J.P. New advances in fertility preservation for pediatric cancer patients. Curr. Opin. Pediatr. 2011, 23, 9–13.
77. Pacey, A.A. Fertility issues in survivors from adolescent cancers. Cancer Treat. Rev. 2007, 33, 646–655.
78. Crawshaw, M.A.; Glaser, A.W.; Pacey, A.A. The use of pornographic materials by adolescent male cancer patients when banking sperm in the UK: Legal and ethical dilemmas. Hum. Fertil. Camb. 2007, 10, 159–163.
79. Berookhim, B.M.; Mulhall, J.P. Outcomes of operative sperm retrieval strategies for fertility preservation among males scheduled to undergo cancer treatment. Fertil. Steril. 2014, 101, 805–811.
80. Hagenas, I.; Jorgensen, N.; Rechnitzer, C.; Sommer, P.; Holm, M.; Schmiegelow, K.; Daugaard, G.; Jacobsen, N.; Juul, A. Clinical and biochemical correlates of successful semen collection for cryopreservation from 12–18-year-old patients: A single-center study of 86 adolescents. Hum. Reprod. 2010, 25, 2031–2038.
81. Chong, A.L.; Gupta, A.; Punnett, A.; Nathan, P.C. A cross Canada survey of sperm banking practices in pediatric oncology centers. Pediatr. Blood Cancer 2010, 55, 1356–1361.
82. Ginsberg, J.P.; Ogle, S.K.; Tuchman, L.K.; Carlson, C.A.; Reilly, M.M.; Hobbie, W.L.; Rourke, M.; Zhao, H.; Meadows, A.T. Sperm banking for adolescent and young adult cancer patients: Sperm quality, patient, and parent perspectives. Pediatr. Blood Cancer 2008, 50, 594–598.
83. Shnorhavorian, M.; Kroon, L.; Jeffries, H.; Johnson, R. Creating a standardized process to offer the standard of care: Continuous process improvement methodology is associated with increased rates of sperm cryopreservation among adolescent and young adult males with cancer. J. Pediatr. Hematol. Oncol. 2012, 34, e315–e319.
84. Ginsberg, J.P.; Carlson, C.A.; Lin, K.; Hobbie, W.L.; Wigo, E.; Wu, X.; Brinster, R.L.; Kolon, T.F. An experimental protocol for fertility preservation in prepubertal boys recently diagnosed with cancer: A report of acceptability and safety. Hum. Reprod. 2010, 25, 37–41.
85. Orwig, K.E.; Schlatt, S. Cryopreservation and transplantation of spermatogonia and testicular tissue for preservation of male fertility. J. Natl. Cancer Inst. Monogr. 2005, 34, 51–56.
86. Wyns, C.; Curaba, M.; Vanabelle, B.; Van Langendonckt, A.; Donnez, J. Options for fertility preservation in prepubertal boys. Hum. Reprod. Update 2010, 16, 312–328.
87. Jahnukainen, K.; Hou, M.; Petersen, C.; Setchell, B.; Soder, O. Intratesticular transplantation of testicular cells from leukemic rats causes transmission of leukemia. Cancer Res. 2001, 61, 706–710.
88. Ginsberg, J.P.; Li, Y.; Carlson, C.A.; Gracia, C.R.; Hobbie, W.L.; Miller, V.A.; Mulhall, J.; Shnorhavorian, M.; Brinster, R.L.; Kolon, T.F. Testicular tissue cryopreservation in prepubertal male children: An analysis of parental decision-making. Pediatr. Blood Cancer 2014, 61, 1673–1678.
89. Pacey, A.A.; Eiser, C. Banking sperm is only the first of many decisions for men: What healthcare professionals and men need to know. Hum. Fertil. Camb. 2011, 14, 208–217.
90. Pacey, A.; Merrick, H.; Arden-Close, E.; Morris, K.; Rowe, R.; Stark, D.; Eiser, C. Implications of sperm banking for health-related quality of life up to 1 year after cancer diagnosis. Br. J. Cancer 2013, 108, 1004–1011.
91. Yee, S.; Fuller-Thomson, E.; Dwyer, C.; Greenblatt, E.; Shapiro, H. “Just what the doctor ordered”: Factors associated with oncology patients’ decision to bank sperm. Can. Urol. Assoc. J. 2012, 6, E174–E178.
92. Wasilewski-Masker, K.; Seidel, K.D.; Leisenring, W.; Mertens, A.C.; Shnorhavorian, M.; Ritenour, C.W.; Stovall, M.; Green, D.M.; Sklar, C.A.; Armstrong, G.T.; et al. Male infertility in long-term survivors of pediatric cancer: A report from the childhood cancer survivor study. J. Cancer Surviv. 2014, 8, 437–447.
93. Green, D.M.; Zhu, L.; Zhang, N.; Sklar, C.A.; Ke, R.W.; Kutteh, W.H.; Klosky, J.L.; Spunt, S.L.; Metzger, M.L.; Navid, F.; et al. Lack of specificity of plasma concentrations of inhibin B and follicle-stimulating hormone for identification of azoospermic survivors of childhood cancer: A report from the St Jude lifetime cohort study. J. Clin. Oncol. 2013, 31, 1324–1328.
94. Romerius, P.; Stahl, O.; Moell, C.; Relander, T.; Cavallin-Stahl, E.; Wiebe, T.; Giwercman, Y.L.; Giwercman, A. Hypogonadism risk in men treated for childhood cancer. J. Clin. Endocrinol. Metab. 2009, 94, 4180–4186.
95. Dohle, G.R. Male infertility in cancer patients: Review of the literature. Int. J. Urol. 2010, 17, 327–331.
96. Signorello, L.B.; Mulvihill, J.J.; Green, D.M.; Munro, H.M.; Stovall, M.; Weathers, R.E.; Mertens, A.C.; Whitton, J.A.; Robison, L.L.; Boice, J.D., Jr. Congenital anomalies in the children of cancer survivors: A report from the childhood cancer survivor study. J. Clin. Oncol. 2012, 30, 239–245.
97. Winther, J.F.; Boice, J.D., Jr.; Mulvihill, J.J.; Stovall, M.; Frederiksen, K.; Tawn, E.J.; Olsen, J.H. Chromosomal abnormalities among offspring of childhood-cancer survivors in Denmark: A population-based study. Am. J. Hum. Genet. 2004, 74, 1282–1285.
98. Eiser, C.; Arden-Close, E.; Morris, K.; Pacey, A.A. The legacy of sperm banking: How fertility monitoring and disposal of sperm are linked with views of cancer treatment. Hum. Reprod. 2011, 26, 2791–2798.
99. Merrick, H.; Wright, E.; Pacey, A.A.; Eiser, C. Finding out about sperm banking: What information is available online for men diagnosed with cancer? Hum. Fertil. Camb. 2012, 15, 121–128.
100. Kim, J.; Kim, K.H.; Mersereau, J.E. Building a successful fertility preservation program at a major cancer center. J. Gynecol. Oncol. 2014, 25, 148–154.
101. Blough, K.; Mansfield, C.; Kondapalli, L.A. Seamless integration of clinical care and research in an innovative fertility preservation program: The Colorado Oncofertility Program model. J. Cancer Surviv. 2014; doi: 10.1007/s11764-014-0362-6.